✦ LIBER ✦

A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema

✍ Scribed by Marla B. Sultan; Duo Zhou; Jane Loftus; Theresa Dombi; Kathleen S. Ice

Book ID: 116806172
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 997 KB
Volume: 118
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2011.02.045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Randomized Double-Masked Tria

A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Intravitreal Triamcinolone for Refractor

Intravitreal Triamcinolone for Refractory Diabetic Macular Edema: Two-Year Results of a Double-Masked, Placebo-Controlled, Randomized Clinical Trial

✍ Mark C. Gillies; Florian K.P. Sutter; Judy M. Simpson; Jorgen Larsson; Haipha Al 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Intravitreal triamcinolone for diabetic

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-monthefficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial

✍ Florian K.P. Sutter; Judy M. Simpson; Mark C. Gillies 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Adapalene gel 0.3% for the treatment of

Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial

✍ Diane Thiboutot; David M. Pariser; Nancy Egan; Javier Flores; James H. Herndon J 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Results of a multicenter, randomized, do

Results of a multicenter, randomized, double-blind, dose-evaluating phase 2/3 study of lenalidomide in the treatment of metastatic malignant melanoma

✍ John Glaspy; Michael B. Atkins; Jon M. Richards; Sanjiv S. Agarwala; Steven O'Da 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Sodium L-ascorbyl-2-phosphate 5% lotion

Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial

✍ Heather Woolery-Lloyd; Leslie Baumann; Hiroshi Ikeno 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB